Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tg Therapeutics (TGTX) Equity Ratio: 2016-2025

Historic Equity Ratio for Tg Therapeutics (TGTX) over the last 10 years, with Sep 2025 value amounting to 0.59.

  • Tg Therapeutics' Equity Ratio rose 80.66% to 0.59 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.59, marking a year-over-year increase of 80.66%. This contributed to the annual value of 0.38 for FY2024, which is 20.96% down from last year.
  • Per Tg Therapeutics' latest filing, its Equity Ratio stood at 0.59 for Q3 2025, which was up 50.57% from 0.39 recorded in Q2 2025.
  • In the past 5 years, Tg Therapeutics' Equity Ratio registered a high of 0.81 during Q1 2021, and its lowest value of 0.14 during Q1 2023.
  • Moreover, its 3-year median value for Equity Ratio was 0.39 (2025), whereas its average is 0.39.
  • In the last 5 years, Tg Therapeutics' Equity Ratio soared by 6,208.90% in 2021 and then plummeted by 75.28% in 2023.
  • Quarterly analysis of 5 years shows Tg Therapeutics' Equity Ratio stood at 0.62 in 2021, then slumped by 51.55% to 0.30 in 2022, then soared by 60.90% to 0.49 in 2023, then declined by 20.96% to 0.38 in 2024, then spiked by 80.66% to 0.59 in 2025.
  • Its Equity Ratio was 0.59 in Q3 2025, compared to 0.39 in Q2 2025 and 0.36 in Q1 2025.